These words uttered in 1901 relate directly to studies of thrombolytics for AMI. In GISSI-1 and 2 other major thrombolysis trials, the investigators did not require an informed consent of the patients ...
Patients with stroke due to blood clots in brain arteries ('ischaemic stroke') can be treated with clot-dissolving drugs called 'thrombolytics'. By dissolving blood clots, thrombolytic drugs improve ...
CAMBRIDGE, Mass., Thrombolytic Science, LLC (TSI) today announced initiation of a Phase 2 clinical trial to confirm the efficacy and safety of its sequential dual-treatment regimen of low-dose tissue ...
(HealthDay News) — Among patients with pulmonary embolism, thrombolytic therapy is associated with lower rates of all-cause mortality but increased risks of major bleeding and intracranial hemorrhage ...
BOTHELL, Wash.--(BUSINESS WIRE)--EKOS Corporation, a privately held medical device company located in Bothell, Washington, announced the results of DUET, the world’s first and only multi-center ...
HSINCHU, Taiwan--(BUSINESS WIRE)--As COVID-19 vaccination has raised the issue of thrombosis, Dr. Chih-Kuang Yeh, Distinguished Professor of the Department of Biomedical Engineering and Environmental ...
Medications for pulmonary embolism may decrease the size of blood clots, help dissolve them, or reduce the risk of recurrence. All of these medications carry the risk of bleeding. A pulmonary embolism ...
The proof of efficacy of thrombolysis for acute myocardial infarction (AMI) depends on 9 randomized placebo-controlled trials totaling 58,511 patients. The meta-analysis of these trials showed an ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback